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Abstract
Chronic anal fissure’s (CAF) etiopathogenesis remain unclear. CAF of the posterior commissure (CAPF) are often character-
ized by internal anal sphincter (IAS) hypertonia. The treatment of this disease aimed to reduce IAS hypertonia. Due to the 
high rate of anal incontinence after LIS, the employment of sphincter preserving surgical techniques associated to pharma-
cological sphincterotomy appears more sensible. The aim of our study is to evaluate the long-term results of fissurectomy 
and anoplasty with V–Y cutaneous flap advancement associated to 30 UI of botulinum toxin injection for CAPF with IAS 
hypertonia. We enrolled 45 patients undergone to fissurectomy and anoplasty with V–Y cutaneous flap advancement and 30 
UI botulinum toxin injection. All patients were followed up for at least 5 years after the surgical procedure, with evaluation 
of anal continence, recurrence rate and MRP (Maximum resting pressure), MSP (Maximum restricting pressure), USWA 
(Ultrasound wave activity). All patients healed within 40 days after surgery. We observed 3 “de novo” post-operative anal 
incontinence cases, temporary and minor; the pre-operative ones have only temporary worsened after surgery. We reported 
3 cases of recurrences, within 2 years from surgery, all healed after conservative medical therapy. At 5 year follow-up post-
operative manometric findings were similar to those of healthy subjects. At 5 years after the surgical procedure, we achieved 
good results, and these evidences show that surgical section of the IAS is not at all necessary for the healing process of the 
CAPF.
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Introduction
Chronic anal fissure (CAF) is one of the most frequent 
proctological disease, its clinical features are post-defeca-
tion bleeding, itching and pain, which can last from few 
minutes–hours. CAF most frequently occur at the poste-
rior commissure (CAPF) [1], nevertheless, to present the 
etiopathogenesis of the disease remains unclear. CAPF are 
characterized, more often than CAF at the anterior commis-
sure, by internal anal sphincter (IAS) hypertonia. To date, 
the role of this latter feature is unknown, and we still won-
der whether it is a cause or a consequence of CAF disease. 
During the last few decades, the treatment of this disease 
aimed to reduce IAS hypertonia with medical or surgical 
techniques. Surgical lateral internal sphincterotomy (LIS) 
represents nowadays the gold standard treatment for CAFs, 
which are refractory to the pharmacological therapy; this 
surgical procedure is burdened by low rate of post-operative 
complications and high healing rate. The great disadvantage 
of the latter procedure is the high rate of anal incontinence, 
which can occur in up to 30–40% of cases. A recent meta-
analysis [2] evaluating long-term incidence of anal inconti-
nence after LIS, showed an overall continence alteration risk 
of 14%; however, on severity analysis, flatus incontinence 
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and soilage/seepage were much commoner than frank incon-
tinence to liquid or solid stool.
Anal incontinence has a strong impact on the quality of 
life of patients and it can be more disabling than CAF itself 
[3]; as a matter of fact, patients tend to bear better the recur-
rence than the fecal incontinence [4].
To preserve the anatomical and functional integrity of 
the sphincterial system as well as to reduce the anal inconti-
nence incidence, the surgical procedures mostly used for the 
treatment of CAPF are fissurectomy alone or fissurectomy 
and pharmacological sphincterotomy, which can be associ-
ated with cutaneous and mucous flap.
The aim of our study is to evaluate the results of fissurec-
tomy and anoplasty with V–Y cutaneous flap advancement 
associated to 30 UI of botulinum toxin injection, at 5 years 
after the sphincter-saving surgical procedure, as a treatment 
for CAPF with IAS hypertonia.
Materials and methods
We enrolled 45 patients, all affected by idiopathic and non-
recurrent CAPF with hypertonic IAS, who underwent fis-
surectomy and anoplasty with V–Y cutaneous flap advance-
ment and 30 UI botulinum toxin injection, from January 
2011 until January 2015. All patients were followed up for 
at least 5 years after the surgical procedure. The patients’ 
outcome data were retrieved from a prospectively monitored 
database.
Pre-operative manometric evaluation was performed after 
a reasonable period of suspension of all medical therapy 
influencing IAS tone. The manometric evaluation was car-
ried out by a manometric sensor (2.1 mm external diam-
eter) with four circle orifices and a latex microbaloon at its 
extremity (Marquat C87; Boissy, St-Leger, France). The 
machine was connected to a polygraph (Narco; Byosystem 
MMS 200, Houston TX) using the station pull-through 
method with perfusion of normal saline and the patient lying 
on the right side. At manometric evaluation, maximum rest-
ing pressure (MRP) and maximum squeeze pressure (MSP) 
were defined as the maximum pressure detected, respec-
tively, on resting and after voluntary contraction. Ultraslow 
wave activity (USWA) was defined as pressure’s waves with 
frequency of less than 2/min and an amplitude greater than 
25 cm  H2O [5].
Data collected on healthy subjects by our anorec-
tal pathophysiological laboratory showed [6] that the 
normal values of MRP and MSP were, respectively, 
68.1 ± 12.3 mmHg mmHg and 112 ± 36,2 mmHg; USWA 
was detected in the 10% of patients. In accordance to Jones 
et al. [7], normal range of MRP was 45–85 mmHg; so that 
CAAF with hypertonic IAS were defined as those with MRP 
values > 85 mmHg. Manometric follow-up was performed at 
12 and 60 months after the surgery.
All patients underwent fissurectomy and anoplasty with 
V–Y skin flap advancement lying in a gynecological posi-
tion under spinal or general anesthesia. To expose the anal 
canal we used four Kocher pliers placed at 3, 6, 9 an 12 h to 
avoid employing anal retractors; an Eisenhammer retractor 
or a speculum have been gently introduced just in case of 
necessity.
After injection of 5  ml of local anesthetic solution 
(100 mg hydrochloride mepivacaine an 0.025 mf l-adrena-
line), the fibrotic edges were excised with a scalpel until nor-
mal non-fibrotic anodermal tissue showed sufficient bleed-
ing. The sentinel skin tag and hypertrophied papilla at the 
level of dentate line were excised when present according to 
Gupta and Kalaskar [8]. The tissue at the base of the fissure 
was curetted until there were clean muscle fibers of the IAS. 
There was no use of diathermy and careful attention was 
payed to avoiding damages of the IAS. Standard advance-
ment anoplasty was performed using a flap of healthy skin 
tissue which was mobilized and then advanced with its blood 
supply to fill in the defect. The flap was secured without 
tension to the anal canal and the skin was closed tension 
free in a V–Y manner with interrupted rapid absorbable 
suture behind the advancement flap. Once the fissurectomy 
and anoplasty was performed, the botulinum toxin (BT) A 
(Botox, Allergan, Westport, Ireland) store at − 20 °C and 
diluted in saline to 50 UI/ml was injected into IAS with a 
27-gauge needle. Each patient received a total of 30 UI of 
BT: 15 UI injected at 3 h in gynecological position and 15 
UI injected at 9 h. None of the patients assumed concomitant 
oral medications that could interfere with the action of type 
A BT (aminoglycosides, baclofen, dantrolene, diazepam) 
and there was no known hypersensitivity to any component 
of BT formulation. All procedures were carried out by the 
same senior surgeon (GDV). Before surgery, all patients 
received a small volume of phosphate–saline enema. Metro-
nidazole was administered intravenously in a dose of 500 mg 
1 h before surgery. Subsequently, it was administered per os 
at the dosage of 250 mg for 7 days, three times daily.
During the first 2 weeks after the surgery, patients took 
variable doses of psyllium fibers. A laxative preparation 
(sennosides) was given orally to subjects who had not yet 
passed stools 3 days after surgery. Enema, suppositories and 
all rectal manipulation were avoided. Immediately after sur-
gery, all patients received 100 mg of diclofenac intramuscu-
larly for analgesia and were instructed to take only 100 mg 
of nimesulide tablets when needed. The primary goal of the 
study was the patient’s complete healing and the evalua-
tion of incontinence and recurrence rate; the secondary goal 
included the evaluation of MRP, MSP, USWA, symptom 
relief (bleeding, itching and pain) and recording pro forma 
of the immediate an long time complications related to flap 
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(anal stenosis, keyhole deformity, urinary retention, related 
side effects of BT). A complete healing was defined as a 
complete epithelialization of the advancement skin flap. 
Both duration and intensity of pain post-defecation were 
evaluated. Pain intensity was scored with a visual analogi-
cal scale (VAS) from 0 to 10, where 0 corresponded to no 
pain and 10 to the worst pain conceivable. Anal inconti-
nence was assessed pre-operatively and after 1, 3, 6, 12 and 
60 months from surgery using the Pescatori grading system 
[9]: A incontinence for flatus and mucus; B for liquid stool; 
C for solid stool; 1 for occasional; 2 for weekly and 3 for 
daily. Patients were discharged 24 h after surgery, afterwards 
they were examined until they were completely healed and 
they were also followed up at 1, 12 and 60 months follow-
ing the surgical procedure. Independently of the scheduled 
appointments, patients were seen on request.
Statistical analysis
Continuous variables were expressed as a mean with stand-
ard deviation and qualitative data as absolute frequencies, 
MRP values were also given as median and range. Student’s 
t test with Welch correction was used to analyze the dif-
ferences of pain score and pain duration at each registra-
tion point. Values of P < 0.05 were considered statistically 
significant.
Results
This study includes 15 women and 30 men. At the time 
of surgical procedure, the median age of the patient was 
39 years (range 18–72). Bowel function was normal in 13 
patients, 26 patients suffered from constipation and 6 from 
diarrhea; bowel function was assessed according to the 
updated Rome diagnostic criteria. Seven women were nul-
liparous, 4 gave natural birth and all of them underwent an 
episiotomy and 4 patients gave birth throughout a caesarean 
section. Clinical features of AF are reported in Table 1.
Healing fissure and relief of symptoms
We achieved complete wound healing, in all patients, within 
40 days after surgery. Intensity and duration of post-defeca-
tion pain was significantly reduced with respect to the pre-
operative values starting from the first defecation (P < 0.001) 
(Fig. 1). None of the patients complained about pain, bleed-
ing or itching 40 days after surgery. Analgesics consumption 
decreased significantly after first defecation.
Incontinence
We recorded 3 cases of pre-operatory anal incontinence 
(6.6%), 2 cases were type A1 and one was type A2 accord-
ing to Pescatori grading system. In 2 of these patients, anal 
incontinence resulted worsened at 1 month follow-up after 
Table 1  Characteristics of Chronic Anal fissure
No. Per cent
Hypertrophied anal papilla 36 80
Skin tags 30 66,6
Symptoms
 Pain 45 100
 Bleeding 34 75,5
 Pruritus 22 48,8
 Duration of Symptoms
  Months (mean ± standard 
deviation)
20,1 ± 15,2
Fig. 1  Intensity and duration 
of pain related to defecation 
after fissurectomy and anal 
advancement. Star statistically 
significant difference from the 
pre-operative values: P < 0.001
statistically significant difference from the pre-operative values: P<0,001 
0
1
2
3
4
5
6
7
8
9
10
0
50
100
150
200
250
preop. 1°def. 3°def. 5°def 7°def 9°def. 10°def.
duraon of pain (0-250 min) intensity of pain (VAS 0-10)
 Updates in Surgery
1 3
surgery, while at 3 month follow-up, the grading score was 
similar than the pre-operative recorded one, Table 2. We 
observed only 3 “de novo” anal incontinence cases but in 
all of them the alteration was minor and temporary, Table 3.
Recurrences
We reported only 3 cases of recurrences, 2 women and 1 
man, the site of the recurrences was always different from 
the primary location. All of them occurred within 2 years 
from surgery and all were characterized by the persistence of 
IAS hypertonia. All patients underwent a medical treatment 
consisting in implementation of fibers in the diet, employ of 
local products containing nifedipine or lidocaine and anal 
dilators. All patients responded to the conservative treatment 
with a complete healing.
Manometry findings
Pre-operative values of MRP were significantly higher 
as compared with healthy subjects (101 ± 15  mmHg; 
P = 0.001), whereas MSP values were only slightly increased 
(125 ± 16.8 mmHg; P = n.s.).
At 12 months and 60 months after surgery MSP values 
did not significantly differ as compared both with pre-oper-
ative levels and healthy control subjects.
At 12 month follow-up, MRP values were significantly 
lower as compared with pre-operative values (P < 0.001). 
As compared with healthy controls, MRP values had still 
increased (P < 0.01). At 60 months, MRP values were simi-
lar compared with healthy control subjects (P = n.s.).
Pre-operative, the presence of USWA was detected in 
11 of 45 (24.4%). A comparison among healthy subjects 
and patients with CAPF showed a significant difference 
(P < 0.001).
At 12 month follow-up, the detected rate of USWA was 
lower in comparison to pre-operative values (P < 0.05) but 
they were not significantly higher as compared with healthy 
subjects. At 60 month follow-up the USWA values of CAPF 
patient were not statistically significantly different form the 
ones of healthy subjects.
Complications and follow‑up
There were no cases of urinary retention, anal stenosis or 
keyhole deformity. No necrosis of the transposed flap was 
observed. We did not report any local complications related 
to the injection of the BT. The only complications recorded 
post-operatively were of slight entity and in no case required 
further surgery; in particular, 3 infections were detected in 
the donor site and a partial break down of the flap occurred 
in one case.
Discussion
The results of our study show that fissurectomy and ano-
plasty associated with the injection of BT, as treatment for 
patients affected by CAPF with IAS hypertonia, allows an 
immediate resolution of clinical symptoms as well as a fast 
healing of the wounds. We recorded a low rate of recurrence 
(6.7%); we observed only 3 “de novo” case of post-opera-
tory anal incontinence, which were temporary and of slight 
entity; patients who were already suffering experienced a 
temporary worsening. Moreover, MRP values started signifi-
cantly reducing from 12 months [10] after the procedure to 
reach, at 60 months after surgery, values which were similar 
to healthy subjects.
Fissurectomy is the most common surgical procedure 
used to preserve structural and functional integrity of the 
IAS. It consists in the in the excision of the CAF and it can 
be associated with the removal of the hypertrophied anal 
papilla and skin tags. Fissurectomy, as a wound debride-
ment, removes the bradytrophic scar tissue and produces 
fresh wound edges, creating an acute fissure. Fissure exci-
sion without interfering with the IAS was first reported by 
Table 2  Evaluation of pre-operative anal incontinence cases accord-
ing to Pescatori grading system from 1 month to 60 months after the 
surgical procedure
Pre-oper-
ative
Anal 
incon-
tinence 
cases
1 month 
after the 
proce-
dure
3 months 
after the 
proce-
dure
6 months 
after the 
proce-
dure
12 months 
after the 
procedure
60 months 
after the 
procedure
A2 A2 A2 A2 A2 A1
A1 A2 A1 A1 A1 A1
A1 A2 A1 – – A1
Table 3  Evaluation of post-operative “de novo” anal incontinence 
cases according to Pescatori grading system from 1 to 60  months 
after the surgical procedure
Post-
operative 
“de 
novo”
Anal 
incon-
tinence 
cases
1 month 
after the 
proce-
dure
3 months 
after the 
proce-
dure
6 months 
after the 
proce-
dure
12 months 
after the 
procedure
60 months 
after the 
procedure
1 A1 – – – –
2 A1 A1 – – –
3 A2 A1 – – –
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Ashton in 1854, it was recognized to be an effective therapy 
for CAF, but it was abandoned due to its complications, such 
as keyhole deformity, which can lead to fecal incontinence 
[11]. Nevertheless, it has been recently reconsidered as a 
valid treatment for CAF both in children and adults [12]. 
This latter surgical procedure has been associated with 
pharmacological sphincterotomy to improve its results, 
as well as reduce its complications [15–20]. After surgi-
cal fissurectomy, with or without association with chemi-
cal sphincterotomy [13, 15, 21–26], we observe a complete 
second intention wound healing, even after 10 weeks and 
the rate of failure con reach the 34% [24]. The rate of recur-
rence reaches up to the 37% in some series [22]. The high 
rate of recurrence and healing failure of fissurectomy might 
be related to the fact that this surgical procedure leaves a 
naked ischemic area, whose previous blood supply arrives 
from some branches of rectal inferior arteries, which cross 
the hypertonic IAS fibers [27–29]; in this regard the employ 
of drugs enabling to reduce the IAS tone aims to improve the 
blood supply of the naked area.
The employ of a skin graft after fissurectomy was first 
described by Ruiz-Moreno in 1968.The use a flap to cover 
up for the naked area after fissurectomy is designed to relo-
cate on this area healthy and fresh blood supplied tissue, per-
fused by other arterial districts. Another possible advantage 
of using a flap might be represented by the enlarging effect 
on the cutaneous circumference of the anal canal, which 
reduces the risk of splitting.
Several surgical techniques for the use of flaps have been 
described, we number among them the employ of skin or 
mucous flaps, skin ones are most frequently hired. Various 
type of skin flaps are known, such as sliding skin grafts, 
house advancement flap, V–Y advancement anoplasty, 
island advancement flap and rotation flaps [31–35].
Surgical procedures that involve the employment of flap 
guarantee shorter healing period and lower incidence of non- 
healed wound or recurrence and a minimal interference with 
the anal continence than the ones observed after surgical 
fissurectomy itself with or without association with phar-
macological sphincterotomy [14, 30, 36, 37]. Fissurectomy 
associated with anoplasty is a surgical procedure employed 
for both patients with hypertonic IAS and normotonic IAS 
[35, 38]. Under the light of the brilliant results of this sur-
gical procedure, some authors suggest using fissurectomy 
with anal advancement flap as the first line therapy for CAF 
[30, 39–41].
At the best of our knowledge, the association of fissurec-
tomy with anoplasty and pharmacological sphincterotomy 
has been cited in one of our series [38, 42] and subsequently 
in a study published by Halahakoon et al. [43].
In this study, we associated the injection of BT in the IAS 
to the fissurectomy and anoplasty with V–Y skin advance-
ment flap, to temporarily reduce the IAS pressure [44]. BT 
A prevents release of acetylcholine at the presynaptic nerve 
endings and blocks the neuromuscular transmission, thus 
causing a chemical enervation of the sphincter muscles. 
Nevertheless, this procedure is not free of risks, most fre-
quently observed complications are peri-anal thrombosis, 
infections and anal incontinence. In this regard, we noticed 
that patients affected by pre-operative anal incontinence, 
experienced an immediate post-operatory worsening of the 
alteration, which diminished to pre-operatory level straight 
after 6 months; even for the 3 “de novo” cases, that we 
observed in the study, anal incontinence has been tempo-
rary and of slight entity but related to the BT action. The 
only surgical related complications we were able to record 
were of slight entity and they never required further surgery. 
Moreover, we recorded 3 cases of recurrence, which have 
not occurred at the same site as the original lesion and all 
healed with medical therapy; this might be because of the 
durability of the advancement flap [30].
However, during the fissurectomy with or without 
advancement flap, some steps may compromise the integ-
rity of IAS. Therefore, it is mandatory to perform it with 
a scalpel to avoid excision or cauterization of the IAS fib-
ers. It’s also useful not to use anal retractors, unless neces-
sary and used for a brief period of time. In their prospective 
randomized clinical Zimmermann et al. [45] showed that 
trans anal advancement flap for high trans sphincteric fis-
tula results in a significant reduction of MRP values and 
increase of anal incontinence rate after use of Park retractor 
when compared with the use of Scott retractor. Van Tets 
et al. [46] conducted a study in patients who underwent 
closed hemorrhoidectomy and showed that the reduction of 
MRP values was greater when a Park retractor was used; 
they also suggested that overstretching of anal sphincter by a 
Parks retractor may lead to small nerve branches rupture and 
consequently to the denervation of IAS fibers. As a matter 
of fact, in animal studies [47], it has been shown that pro-
longed stretching may cause local necrosis of external anal 
sphincter fibers. In view of these latter findings in our study 
we reached a good exposure of the anal canal just using 4 
Kocher pliers placed at 3,6,9 and 12 h in gynecological posi-
tion or just rarely using an anal retractor.
Conclusion
At 5 years after the surgical procedure we achieved good 
results and observed that post-operative manometric findings 
were similar to those of healthy subjects; these evidences 
show us the surgical section of the IAS is not at all necessary 
for the healing process of the CAPF.
In conclusion, further randomized trials comparing fis-
surectomy alone versus fissurectomy associated with graft 
and drugs enabling the reduction of IAS tone are needed to 
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better define their role in the treatment of CAPF with IAS 
hypertonia.
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